Skip to Content

Aurodex Ear Drops

Generic Name: antipyrine, benzocaine
Dosage Form: otic solution

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Antipyrine and Benzocaine Otic Solution, USP Rx Only 15 mL

DESCRIPTION: Each mL contains:

Antipyrine..........54  mg  (5.4%)

Benzocaine..........14.0 mg (1.4%)

(also contains glycerin and oxyquinoline sulfate)


AurodexTM Antipyrine and Benzocaine Otic Solution is an otic solution containing antipyrine, benzocaine, oxyquinoline sulfate and anhydrous glycerin for use in the ear. The solution congeals at 0oC (32 oF) but returns to normal consistency, unchanged at room temperature.

Antipyrine is an analgesic with local anesthetic action, it is chemically 2,3-dimethyl-1-phyl-3-pyrazolin-5-one. Antipyrine occurs as colorless crystals or white powder, has a slightly bitter taste and is soluble in water and alcohol.


Benzocaine is a local anesthetic. it is chemically ethyl-p-aminobenzoate or Benzoic Acid, 4-amino, ethyl ester. The active ingredients are represented by the following structural formula

      

AurodexTM Antipyrine and Benzocaine Otic Solution comibine the hygroscopic property of anhydrous glycerin with the analgesic action of antipyrine and benzocaine to relieve pressure, reduce inflammation and congestion, and alleviate pain and discomfort in acute otitis media. AurodexTM Antipyrine and Benzocaine Otic Solution does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture

Indications and Usage: Acute Otitis Media of Various Etiologies

Prompt relief of pain and reduction of inflammation in the congestive and serous stages.

Adjuvant therapy during systemic antibiotic administration for resolution of the infection.

Because of the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is a frequent problem, epecially in children in whom the tube is shorter, wider and more horizontal than in adults.

Removal of Cerumen

Facilitates the removal of excessive or impacted cerumen

Contraindications: AurodexTM Antipyrine and Benzocaine Otic Solution is contraindicated in any person with hypersensitivity to any of the components or substances related tot hem. This product is contraindicated in the presence of spontaneous perforation of the tympanic membrane or discharge.

Warnings: FOR USE IN EARS ONLY NOT FOR USE IN EYES

KEEP OUT OF REACH OF CHILDREN

Discontinue promptly if sensitization or irritation occurs.

Precautions: Information for Patients: Avoid contaminating the dropper tip with material from the ear fingers or other source.

CARCONOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY: No long-term studies in animals or humans have been conducted.

PREGNANCY CATEGORY C:

Animal reproduction studies have not been conducted with AurodexTM Antipyrine and Benzocaine Otic Solution. It is also not known whether AurodexTM Antipyrine and Benzocaine Otic Solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. AurodexTM Antipyrine and Benzocaine Otic Solution should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when AurodexTM Antipyrine and Benzocaine Otic Solution is administered to a nursing woman.

DOSAGE AND ADMINISTRATION: ACUTE OTITIS MEDIA: Instill AurodexTM Antipyrine and Benzocaine Otic Soution permitting the solution to run along the wall of the canal until it is filled. Avoid touching the ear with dropper. Then moisten a cotton pledget with AurodexTM Antipyrine Benzocaine Otic Solution and insert into the meatus. Repeat every one to two hours until pain an congestion are relieved.


REMOVAL OF CERUMEN: Before: Instill AurodexTM Antipyrine and Benzocaine Otic Solution three times daily for two to three days to help detach cerumen from wall of canal and facilitate removal.

After: AurodexTM Antipyrine and Benzocaine Otic Solution is useful for drying out the canal or relieving discomfort.

Before and after removal of cerumen, a cotten pledget moistened with AurodexTMAntipyrine and Benzocaine Otic Solution should be inserted into the meatus following installation.

Note: After use, do not rinse dropper tip, replace cap and close tightly

Protect solution from light and heat, and do not use if it is brown or contains a precipitate.

DISCARD THIS PRODUCT 6 MONTHS AFTER OPENING.

How Supplied: AurodexTM Antipyrine and Benzocaine Otic Solution is supplied in a 10 mL plastic botle with a dropper tip under cap (NDC 0904-6317-10). Store at 20o-25oC (68o-77oF); excursions permitted to 15o-30oC  (59o-86oF) see USP Controlled Room Temperature). Protect from light and heat.

Manufactured by:
Sonar Products, Inc
Carlstadt, NJ 07072

Distributed by:
Major Pharmaceuticals
31778 Enterprise Drive
Livonia, MI 48150 USA

Usual Dosage: See package insert for complete information.

Storage: Store at 20o-25oC (68o-77oF); excursions permitted to 15o-30oC  (59o-86oF) see USP Controlled Room Temperature). Protect from light and heat.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN

Manufactured by:
Sonar Products, Inc
Carlstadt, NJ 07072

Distributed by:
Major Pharmaceuticals
31778 Enterprise Drive
Livonia, MI 48150 USA

AurodedTM Antipyrine and Benzocaine Otic Solution USP
Rx only 10mL

FOR USE IN THE EARS ONLY. NOT FOR USE IN THE EYES

Active Ingredients
Each mL contains:
Antipyrine...54.0 mg (5.4%)
Benzocaine....14mg (1.4%)

Also contains: Glycerin and Oxyquinoline Sulfate

 
AURODEX 
antipyrine, benzocaine otic solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0904-6317
Route of Administration AURICULAR (OTIC) DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ANTIPYRINE (ANTIPYRINE) ANTIPYRINE 54 mg  in 1 mL
BENZOCAINE (BENZOCAINE) BENZOCAINE 14 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
OXYQUINOLINE SULFATE  
GLYCERIN  
Packaging
# Item Code Package Description
1 NDC:0904-6317-10 10 mL in 1 BOTTLE, DROPPER
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 08/27/2009
Labeler - Major Pharmaceuticals (191427277)
Revised: 09/2012
 
Major Pharmaceuticals



Hide